Profiel
Stuart Chaffee is an Independent Director at ABG Acquisition Corp.
I.
He was previously the Chief Financial Officer at Praxis Precision Medicines, Inc. in 2020 and the Head of Business Operations at Kymera Therapeutics, Inc. from 2016 to 2017.
Dr. Chaffee holds an MBA from The Wharton School of the University of Pennsylvania.
Actieve functies van Stuart Chaffee
| Bedrijven | Functie | Begin |
|---|---|---|
| ABG ACQUISITION CORP. I | Directeur/Bestuurslid | - |
Eerdere bekende functies van Stuart Chaffee
| Bedrijven | Functie | Einde |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | Financieel Directeur/CFO | 02-12-2020 |
| KYMERA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-11-2017 |
Opleiding van Stuart Chaffee
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
ABG Acquisition Corp. I
ABG Acquisition Corp. I Financial ConglomeratesFinance Operates as a blank check company | Finance |
















